Unplanned Interruptions: Unresolved Issues: In Regard to Bese et al. (Int J Radiat Oncol Biol Phys 2007;68:654-661)

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 4, 2007, Pages 1335-1336

  Agarwal, Jai Prakash ^a   Budrukkar, Ashwini ^a   Laskar, Sarbani Ghosh ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; LETTER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TOXICITY; TREATMENT OUTCOME;

APPOINTMENTS AND SCHEDULES; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS;

EID: 35449005404     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.07.2341     Document Type: Letter

References (6)

1. Bese N.S., Hendry J., and Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 68 (2007) 654-661
2. Skladowski K., Maciejewski B., Golen M., et al. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of phase III clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 706-713
3. Pignon J.P., Bourhis J., Domenge C., et al., for the Meta-Analysis of Chemotherapy on Head and Neck Cancer (MACH-NC) Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
4. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
5. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
6. Budach V., Stuschke M., Budach W., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 prospective randomized trial. J Clin Oncol 23 (2005) 1125-1135